Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthesis route from Rutin improves bioavailability and anti-tumor activity. Cost-effective manufacturing for global supply chains.
Patent CN104341336B reveals a novel inorganic base route for Eliquis intermediates, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN108101937A reveals high-purity L-α-GPC synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1255919A details an efficient enantioselective addition reaction for DMP-266 intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a cost-effective total synthesis of racemic tetrandrine via CN113045578A. Enables scalable API intermediate production with reduced environmental impact.
Patent CN110526928A reveals high purity 7-ADCA method. Reduces cost and improves supply chain reliability for API manufacturing significantly.
Novel iron catalyst method for Rimegepant intermediates reduces cost and avoids precious metals ensuring supply chain stability and high purity for global pharmaceutical manufacturing partners.
Patent CN110028547B reveals a novel diosgenin 3-OH derivative with superior antitumor activity. Discover the efficient two-step synthesis route for scalable pharmaceutical manufacturing.
Patent CN105237516A reveals a chromatography-free Ledipasvir synthesis. Discover cost reduction and supply chain advantages for high-purity API manufacturing.
Patent CN112745249A details a high-yield one-pot synthesis for Nifuratel Related Substance B. Discover cost-effective manufacturing and supply chain advantages.
Advanced synthetic route for Nifuratel Related Substance A Hydrochloride via epichlorohydrin. High purity, scalable process for pharmaceutical quality control and impurity profiling.
Patent CN116444500A reveals high-yield Corewski route for Pitavastatin impurity. Ensures supply chain stability and cost reduction in API intermediate manufacturing.
Novel resolution process for high-purity beraprost acid via diastereomeric esterification. Reduces manufacturing costs and ensures supply chain stability for pharmaceutical intermediates.
Patent CN113121383A details a novel synthesis for impurity standards of Fluralaner intermediates, ensuring rigorous quality control and regulatory compliance for veterinary APIs.
Patent CN113336726B details a novel synthesis of (R)-3-propyl-γ-butyrolactone using chiral auxiliaries, offering high purity and cost-effective manufacturing for API intermediates.
Patent CN100343275C details a novel route for glycyl glutamine offering high purity and scalable manufacturing for pharmaceutical supply chains globally.
Novel tangential flow reactor method for prednisolone phosphate. Reduces energy, improves purity. Reliable pharmaceutical intermediates supplier.
Advanced purification technology for Alvimopan ensures high purity and yield. Optimized for commercial scale-up and supply chain reliability in pharmaceutical manufacturing.
Novel process for 6-Fluoropenciclovir using stable ammonium salt intermediates. Reduces cryogenic needs and improves scalability for antiviral API manufacturing.
Novel catalytic route for ciprofloxacin intermediate. High yield, low cost, scalable manufacturing process for pharmaceutical intermediates.